Breast Cancer
News
David Bowie’s death inspires blog on palliative care
David Bowie’s death helped one palliative care specialist broach the subject of end-of-life care with a patient.
News
RCTs vs. observational studies: mortality ‘strikingly’ different following RT
Key clinical point: Analysis of randomized trial data compared with observational data on mortality after breast cancer radiotherapy shows...
News
Significant risk of relapse remains for ER-positive breast cancer patients beyond 10 years
Key clinical point: The risk of breast cancer recurrence continues through 24 years after primary treatments, especially for estrogen receptor–...
Conference Coverage
SABCS: Longer overnight fasting may reduce breast cancer recurrence risk
Lengthening the overnight fasting interval to at least 13 hours may be a novel, easily adoptable strategy to reduce breast cancer recurrence risk...
News
USPSTF supports mammography start at age 50
Women aged 50-74 years should undergo biennial screening mammography, and the decision to screen before age 50 should be individualized, according...
Commentary
A Perfect Storm: The current climate in breast cancer
This five-part series explores the factors that contribute to racial survival disparity in breast cancer and proposes interventions for change.
Conference Coverage
Late risks of breast cancer RT are higher for smokers
Key clinical point: Receipt of radiation therapy had little effect on risks among nonsmokers, but increased the risk of lung cancer and cardiac...
News
BRCA mutation predicts neoadjuvant therapy benefit but is not strongly prognostic
Key clinical point: BRCA1/2 mutation in triple-negative breast cancer is predictive but only weakly prognostic. Major finding: Patients with a...
News
Pembrolizumab shows promise in PD-L1–positive breast cancer
Key clinical point: Pembrolizumab appears safe and modestly active for treatment of ER-positive, HER2-negative advanced breast cancer that...
News
‘Fear and ignorance’ drive rise in bilateral mastectomy
Current trends in surgical treatment of early-stage breast cancer.
News
Buparlisib overcomes endocrine resistance in hormone receptor–positive breast cancer
Key clinical point: Buparlisib modestly improves progression-free survival among women with progressive hormone receptor–positive, HER2-negative...